Show a heart for bones in time - Fractures remain a common problem following cardiac transplantation

Wiener Klinische Wochenschrift

Volumn 116, Issue 5-6, 2004, Pages 151-154

  Dobnig, Harald ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Bone mineral density (BMD); Fractures; Osteoporosis; SHBG; Transplantation

Indexed keywords

CYCLOSPORIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; SEX HORMONE BINDING GLOBULIN; VITAMIN D;

BODY WEIGHT; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; EDITORIAL; FRACTURE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; NUTRITIONAL STATUS; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; TESTOSTERONE BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 1842784948     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03040480     Document Type: Editorial

References (32)

1. Hofbauer LC, Khosla S, Lacey DL, Dunstan CR, Boyle WJ, Riggs BL (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15: 2-12
2. Fahrleitner A, Prenner G, Kniepeiss D, Iberer F, Tscheliessnigg KH, Piswanger-Sölkner C, et al (2002) Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status. Wien Klin Wochenschr 114: 717-724
3. Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Adesso V, et al (1997) Bone mass, vitamin D deficiency and hyperparathyroidism in congestive heart failure. Am J Med 103: 197-207
4. Cohen A, Shane E (2003) Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int 14: 617-630
5. Shane E, Rivas M, McMahon DJ, Staron RB, Silverberg SJ, Seibel MJ, et al (1997) Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab 82: 1497-1506
6. Henderson NK, Sambrook PN, Kelly PJ, Macdonald P, Keogh AM, Spratt P, et al (1995) Bone mineral loss and recovery after cardiac transplantation. Lancet 346: 905
7. Gillard Berguer D, Krieg MA, Thiebaud D, Burckhardt P, Stumpe F, Hurni M, et al (1994) Osteoporosis in heart transplant recipients: a longitudinal study. Transplant Proc 26: 2649-2651
8. Van Cleemput J, Daenen W, Geusens P, Dequecker J, Van de Werf F, Vanhaecke J (1996) Prevention of bone loss in cardiac transplant recipients. Transplantation 61: 1495-1499
9. Fahrleitner A, Prenner G, Leb G, Tscheliessnigg KH, Piswanger-Sö lkner C, Obermayer-Pietsch B, et al (2003) Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation. Bone 32: 96-106
10. Höfle G, Tautermann G, Saely CH, Drexel H (2004) Sex-hormone-binding globulin is negatively correlated with femoral bone mineral density in male cardiac transplant recipients. Wien Klin Wochenschr 116: 170-175
11. Purifoy FE, Koopmans LH, Mayes DM (1981) Age differences in serum androgen levels in normal adult males. Hum Biol 53: 499-511
12. Dunn JF, Nisula BC, Rodbard D (1981) Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 53: 58-68
13. Pardridge WM, Landaw EM (1985) Testosterone transport in brain: primary role of plasma protein-bound hormone. Am J Physiol 249: E534-542
14. Forbes GB, Reina JC (1970) Adult lean body mass declines with age: some longitudinal observations. Metabolism 19: 653-663
15. Davidson JM, Chen JJ, Crapo L, Gray GD, Greenleaf WJ, Catania JA (1983) Hormonal changes and sexual function in aging men. J Clin Endocrinol Metab 57: 71-77
16. Stone K, Bauer DC, Black DM, Sklarin P, Ensrud KE, Cummings SR (1998) Hormonal predictors of bone loss in elderly women: a prospective study. J Bone Miner Res 13: 1167-1174
17. Tromp AM, Ooms ME, Popp-Snijders C, Roos JC, Lips P (2000) Predictors of fractures in elderly women. Osteoporos Int 11: 134-140
18. Van Hemert AM, Birkenhäger JC, de Jong FH, Vandenbroucke JP, Valkenburg HA (1989) Sex hormone-binding globulin in postmenopausal women: a predictor of osteoporosis superior to endogenous oestrogens. Clin Endocrinol (Oxf) 31: 499-509
19. Center JR, Nguyen TV, Sambrook PN, Eisman JA (2000) Hormonal and biochemical parameters and osteoporotic fractures in elderly men. J Bone Miner Res 15: 1405-1411
20. Charpulat RD, Garnero P, Bréart G, Meunier PJ, Delmas PD, for the EPIDOS study group (2000) Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study. J Bone Miner Res 15: 1835-1841
21. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15: 1526-1536
22. Cummings SR, Browner WS, Bauer D, Stone K, Ensrud K, Jamal S, et al (1998) Endogenous hormones and the risk of hip and vertebral fractures among older women. N Engl J Med 339: 733-738
23. von Schoultz B, Carlström K (1989) On the regulation of sex hormone-binding globulin - a challenge of an old dogma and outlines of an alternative mechanism. J Steroid Biochem 32: 327-334
24. Evans DJ, Hoffman RG, Kalkhoff RK, Kissebah RH (1983) Relationship of androgenic activity to body fat topography, fat cell morphology and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 57: 304-310
25. Belgorosky A, Martinez A, Domene H, Heinrich JJ, Bergada C, Rivarola MA (1987) High serum sex hormone-binding globulin (SHBG) and non-SHBG-bound testos-terone in boys with idiopathic hypopituitarism: effect of recombinant human growth hormone treatment. J Clin Endocrinol Metab 65: 1107-1111
26. Hall K, Sara V (1984) Somatomedin levels in childhood, adolescence and adult life. Clinics Clin Endocrinol Metab 13: 91-112
27. Guo CY, Johnson A, Locke TJ, Eastell R (1998) Mechanisms of bone loss after cardiac transplantation. Bone 22: 267-271
28. Sambrook PN, Kelly PJ, Fontana D, Nguyen T, Keogh A, Macdonald P, et al (1994) Mechanisms of rapid bone loss following cardiac transplantation. Osteoporos Int 4: 273-276
29. Shane E, Addesso V, Namerow P, Maybaum S, Staron R, Lo S, et al (2002) Prevention of bone loss after cardiac transplantation with alendronate or calcitriol: efficacy and safety. J Bone Miner Res 17 [Suppl 1]: S135
30. Aris RM, Lester GE, Renner JB, Winders A, Denene Blackwood A, Lark RK, et al (2000) Efficacy of pamidronate for osteoporosis in cystic fibrosis patients following lung transplantation. Am J Respir Crit Care Med 162: 941-946
31. Arlen DJ, Lambert K, Ioannidis G, Adachi JD (2001) Treatment of established bone loss after renal transplantation with etidronate. Transplantation 71: 669-673
32. Lindsay R, Silverman SL, Cooper C, et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285: 320-323